The Safety of Transdermal Nicotine as an Aid to Smoking Cessation in Patients with Cardiac Disease
- 12 December 1996
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 335 (24), 1792-1798
- https://doi.org/10.1056/nejm199612123352402
Abstract
Transdermal nicotine therapy is widely used to aid smoking cessation, but there is uncertainty about its safety in patients with cardiac disease.Keywords
This publication has 29 references indexed in Scilit:
- Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health StudyPublished by American Medical Association (AMA) ,1994
- The effectiveness of the nicotine patch for smoking cessation. A meta-analysisJAMA, 1994
- Cholesterol Changes in Smoking Cessation Using the Transdermal Nicotine SystemPreventive Medicine, 1994
- Myocardial infarction and nicotine patch: a contributing or causative factor?European Heart Journal, 1993
- Nicotine effects on eicosanoid formation and hemostatic function: Comparison of transdermal nicotine and cigarette smokingJournal of the American College of Cardiology, 1993
- Cerebral arterial narrowing with nicotine patchThe Lancet, 1993
- Short-Term Effects of Carbon Monoxide Exposure on the Exercise Performance of Subjects with Coronary Artery DiseaseNew England Journal of Medicine, 1989
- Cigarette smoking and hemostatic functionAmerican Heart Journal, 1988
- Atrial fibrillation while chewing nicotine gumPublished by American Medical Association (AMA) ,1986
- Effect of nicotine on coronary blood‐flow in manClinical Physiology and Functional Imaging, 1985